Formulation and Evaluation of Transdermal Drug Delivery of Piroxicam
Abstract
The aim of the present study was to formulate transdermal films loaded with Piroxicam (PX). Transdermal films were yare by utilizing sodium alginate (SA) and xanthan gum (XG) as biopolymers by varying the coalescence ratios viz., 10:0, 8:2, 6:4, 4:6 and 2:8 (w/w %) through solution casting method. The drug loaded membranes were evaluated for thickness, tensile comportments, and content uniformity. In-vitro diffusion was resolute by Franz diffusion cell. Piroxicam was found to be compatible and stable with the prepared formulation as attested by Fourier transform infrared spectroscopy (FTIR) and Differential Scanning Calorimetry (DSC), studies. Invitro release studies revels efficacy after 24 h. The study results suggest that biopolymer predicated Transdermal films are potential conveyances for amended transdermal distribution of PX for efficacious therapy.
Keywords: Piroxicam, Sodium alginate, Xanthan gum, Transdermal release, Skin permeation
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)1. ________________2. ________________3. ________________4. ________________The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
